Groundbreaking Study Reveals Cadonilimab Superiority in Treating Gastric Cancer: A Potential Leap in Global Cancer Immunotherapy
Akeso, Inc. introduced a real-world study unveiling the success of cadonilimab plus chemotherapy compared to a PD-1 inhibitor combination in first-line treatment for advanced gastric or gastroesophageal junction cancer.
The.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
